血漿置換市場規模、佔有率和成長分析（按產品、技術、流程、應用、最終用戶和地區分類）－2026-2033年產業預測

預計到 2024 年，血漿置換市場規模將達到 13.4 億美元，到 2025 年將達到 14.4 億美元，到 2033 年將達到 26 億美元，在預測期（2026-2033 年）內，複合年成長率為 7.7%。

受多種宏觀經濟和微觀經濟因素的驅動，全球血漿置換療法市場預計將迎來顯著成長。醫療費用支出不斷成長，尤其是在中東和亞太地區，為專注於先進醫療技術的市場相關人員創造了新的機會。人們對重症肌無力、全身性紅斑性狼瘡等免疫系統疾病治療方案的認知不斷提高，進一步推動了市場需求。血漿置換技術的進步及其在獸醫領域的拓展預計將對市場格局產生正面影響。環境因素和人口成長導致自體免疫疾病盛行率上升，推動血漿置換服務需求達到兩位數成長。北美目前佔據領先的市場佔有率，並在未來幾年擁有巨大的成長潛力。

血漿置換市場促進因素

血漿置換市場預計將持續成長，其主要驅動力是血栓性血小板低下紫斑症、Guillain-Barré二氏症候群和重症肌無力等多種自體免疫疾病的日益普遍。人們對這些疾病的認知不斷提高，加上對加強醫療基礎設施建設的日益重視，預計將進一步推動對血漿置換的需求。多個地區對醫療保健領域的投資不斷增加，也有助於推動先進治療方法的應用。尤其是在中東和非洲以及亞太地區，醫療領域的進步預計將在推動對創新醫療解決方案的需求方面發揮關鍵作用，從而進一步促進血漿置換市場的成長。

血漿交換市場的限制

由於人們對血漿置換療法潛在副作用的擔憂，該療法市場面臨顯著挑戰。患者可能會出現血壓下降、心律不整、體溫暫時升高、麻木或癱瘓等症狀。雖然這些副作用通常被認為是輕微的，但它們可能會顯著影響醫療服務提供者和患者接受血漿置換療法作為可行治療方案的意願。因此，市場相關人員可能會面臨血漿置換療法利用率低的問題，這可能會阻礙市場的整體成長和推廣。

血漿置換市場趨勢

由於貧血、胃腸道疾病和癌症等慢性疾病的日益普遍，對血漿衍生療法的需求不斷成長，血漿置換市場正經歷顯著成長。這種需求的激增進一步推動了高效捐血方法的發展。醫療機構正積極創新和改進血漿分離設備，特別是血漿分離機，以提高該療法的有效性和安全性。此外，患者和醫護人員對血漿置換益處的認知不斷提高，也促進了其廣泛應用。總而言之，這些趨勢預示著全球血漿置換市場將呈現強勁的成長動能。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

全球血漿置換市場規模（按產品和複合年成長率分類）（2026-2033 年）

• 裝置
• 消耗品

全球血漿置換市場規模（依技術及複合年成長率分類）（2026-2033 年）

• 薄膜過濾
• 離心

全球血漿置換市場規模（按手術類型和複合年成長率分類）（2026-2033 年）

• 光化學療法
• 低密度脂蛋白血漿置換術
• 血小板分離方法
• 白血球分離術
• 紅血球分離術

全球血漿置換市場規模（按應用及複合年成長率分類）（2026-2033 年）

• 原始血漿採集
• 治療性血漿置換療法
• 免疫學
• 神經病學
• 血液學
• 重症監護
• 腫瘤學
• 風濕病學和整形外科
• 其他治療用途

全球血漿置換市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

• 血庫和血漿採集中心
• 醫院和診所
• 生物製藥公司
• 其他最終用戶

全球血漿置換市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2021-2023年營收年比比較

主要企業簡介

• CSL Limited（Australia）
• Takeda Pharmaceutical Company Limited（Japan）
• Grifols, SA（Spain）
• Baxter International Inc.（United States）
• Kedrion SpA（Italy）
• Octapharma AG（Switzerland）
• Asahi Kasei Medical Co., Ltd.（Japan）
• B. Braun Melsungen AG（Germany）
• Fresenius SE & Co. KGaA（Germany）
• Terumo BCT, Inc.（United States）
• Haemonetics Corporation（United States）
• Cerus Corporation（United States）
• Nikkiso Co., Ltd.（Japan）
• Kawasumi Laboratories, Inc.（Japan）
• Macopharma SA（France）
• Shanghai RAAS Blood Products Co., Ltd.（China）
• China Biologic Products Holdings, Inc.（China）
• LFB SA（France）
• Bio Products Laboratory Ltd.（United Kingdom）
• Sanquin Blood Supply Foundation（Netherlands）

結論與建議

Plasmapheresis Market size was valued at USD 1.34 Billion in 2024 and is poised to grow from USD 1.44 Billion in 2025 to USD 2.6 Billion by 2033, growing at a CAGR of 7.7% during the forecast period (2026-2033).

The global plasmapheresis market is poised for significant growth, driven by various macroeconomic and microeconomic factors. Increasing healthcare expenditures, particularly in regions like the Middle East and Asia Pacific, are creating new opportunities for market players, emphasizing advanced medical care. A growing awareness of treatment options for immune system disorders such as myasthenia gravis and systemic lupus erythematosus is further propelling market demand. Advances in plasmapheresis technology and the expansion into veterinary healthcare are expected to positively influence the market landscape. With autoimmune diseases becoming more prevalent due to environmental factors and population growth, plasmapheresis services are experiencing double-digit demand increases. The North American sector leads in market share and offers substantial growth potential in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Plasmapheresis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Plasmapheresis Market Segments Analysis

Global Plasmapheresis Market is segmented by product, technology, procedure, application, end user and region. Based on product, the market is segmented into instruments and disposables. Based on technology, the market is segmented into membrane filtration and centrifugation. Based on procedure, the market is segmented into photopheresis, Ldl apheresis, plateletpheresis, leukapheresis and erythrocytapheresis. Based on application, the market is segmented into source plasma collection, therapeutic plasmapheresis, immunology, neurology, hematology, critical care, oncology, rheumatology & orthopedics and other therapeutic applications. Based on end user, the market is segmented into blood banks & plasma collection centers, hospital & clinics, biopharmaceutical companies and other end user. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Plasmapheresis Market

The plasmapheresis market is poised for growth driven by an increase in the prevalence of various autoimmune disorders, such as thrombotic thrombocytopenic purpura, Guillain-Barre syndrome, Myasthenia gravis, and others. As awareness of these conditions rises, coupled with an emphasis on enhancing healthcare infrastructure, the demand for plasmapheresis therapy is expected to escalate. The growing investment in healthcare across multiple regions is supporting the wider adoption of advanced treatment options. In particular, developments in regions like the Middle East and Africa, along with Asia Pacific, are likely to play a significant role in driving the demand for innovative healthcare solutions, further boosting the plasmapheresis market.

Restraints in the Plasmapheresis Market

The plasmapheresis market faces notable challenges stemming from concerns related to potential side effects associated with the procedure. Patients may experience issues such as decreased arterial blood pressure, irregular heart rhythms, temporary increases in body temperature, and sensations of tingling or numbness. Although these adverse effects are generally considered mild, they can significantly impact the willingness of healthcare providers and patients to embrace plasmapheresis as a viable treatment option. As a result, stakeholders in the market may encounter hurdles related to declining usage rates of plasmapheresis therapies, which could hinder overall market growth and adoption efforts.

Market Trends of the Plasmapheresis Market

The plasmapheresis market is experiencing significant growth as the demand for plasma-derived therapies rises, driven by an increasing prevalence of chronic diseases such as anemia, gastrointestinal disorders, and cancer. This surge is further propelling the need for efficient blood donation practices. Healthcare organizations are actively innovating and enhancing plasmapheresis equipment, particularly apheresis machines, aiming to improve the efficacy and safety of the procedure. Furthermore, the growing awareness among patients and healthcare professionals about the benefits of plasmapheresis is contributing to its wider acceptance. Overall, these dynamics indicate a robust expansion trajectory for the plasmapheresis market globally.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Plasmapheresis Market Size by Product & CAGR (2026-2033)

• Market Overview
• Instruments
• Disposables

Global Plasmapheresis Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Membrane Filtration
• Centrifugation

Global Plasmapheresis Market Size by Procedure & CAGR (2026-2033)

• Market Overview
• Photopheresis
• Ldl Apheresis
• Plateletpheresis
• Leukapheresis
• Erythrocytapheresis

Global Plasmapheresis Market Size by Application & CAGR (2026-2033)

• Market Overview
• Source Plasma Collection
• Therapeutic Plasmapheresis
• Immunology
• Neurology
• Hematology
• Critical Care
• Oncology
• Rheumatology & Orthopedics
• Other Therapeutic Applications

Global Plasmapheresis Market Size by End User & CAGR (2026-2033)

• Market Overview
• Blood Banks & Plasma Collection Centers
• Hospital & Clinics
• Biopharmaceutical Companies
• Other End User

Global Plasmapheresis Market Size & CAGR (2026-2033)

• North America (Product, Technology, Procedure, Application, End User)
  • US
  • Canada
• Europe (Product, Technology, Procedure, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, Procedure, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, Procedure, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, Procedure, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• CSL Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company Limited (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols, S.A. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kedrion S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Octapharma AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Medical Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius SE & Co. KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo BCT, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haemonetics Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cerus Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nikkiso Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kawasumi Laboratories, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macopharma SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shanghai RAAS Blood Products Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• China Biologic Products Holdings, Inc. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LFB S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio Products Laboratory Ltd. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanquin Blood Supply Foundation (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations